Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Hedge fund Elliott raises pressure on Mitek after takeover bid rejected

Published 11/20/2018, 03:18 PM
Updated 11/20/2018, 03:18 PM
© Reuters.  Hedge fund Elliott raises pressure on Mitek after takeover bid rejected

By Svea Herbst-Bayliss and Liana B. Baker

NEW YORK (Reuters) - Hedge fund Elliott Management on Tuesday asked Mitek Systems Inc (O:MITK) to scrap a so-called "poison pill" to let it buy more stock and said it may press for board changes after the software company took steps to protect itself from the activist investor.

Elliott, which invests more than $34 billion, wrote to Mitek's board and asked for "relief from the poison pill recently enacted" in order to buy as much as 14.9 percent of the company's stock.

Elliott has not disclosed the size of its stake, which includes common stock and swaps, but has said it is one of the company's biggest shareholders.

Mitek did not immediately respond to a request for comment.

Elliott is increasing the pressure on San Diego-based Mitek at a time when software company ASG Technologies, which the hedge fund owns, has been pushing to buy Mitek for $10 a share. Mitek has so far rebuffed the overture.

Mitek's share price has climbed 8.64 percent over the past month and was trading at $9.48 on Tuesday.

Elliott wrote that ASG President and Chief Executive Charles Sansbury first approached Mitek about a possible takeover in August, roughly one week before the company announced that long-serving CEO James DeBello and Chief Financial Officer Jeff Davison would be leaving. Earlier this month, the company said on its earnings call that ASG reached out "after the announcement of our executive changes."

Elliott said Mitek was adopting a "path of entrenchment" and had not properly engaged with the hedge fund.

On Oct. 31, ASG Technologies said it wanted to buy Mitek for $10 a share in cash, a 51 percent premium above the stock's closing price on Oct. 9, 2018.

The hedge fund noted that director Bruce Hansen sold Mitek stock at $8.66 earlier in the year, which prompted it to question, in its letter, why a deal at $10 a share would undervalue the company. Elliott also said a number of board members were stretched thin by serving on too many boards.

The deadline for nominating directors is Dec. 7. Elliott has often asked for board seats.

ASG received an investment last year from Evergreen Coast Capital, the private equity arm of Elliott Management. Elliott has been using Evergreen to acquire both public and private companies, and sometimes involves Evergreen when it pushes companies to explore a sale.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.